Changes in serum cytokine levels in active tuberculosis with treatment

Mediators of Inflammation

Volumn 2005, Issue 5, 2005, Pages 256-262

  Deveci, Figen ^a   Handan Akbulut, H ^a   Turgut, Teyfik ^a   Hamdi Muz, M ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 4; LYMPHOTOXIN; LYMPHOTOXIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; CYTOKINES; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 27644509659     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI.2005.256     Document Type: Article

References (52)

1. Schluger NW, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med. 1998;157(3 pt 1):679-691.
2. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995;273(3):220-226.
3. World Health Organization. Making a Difference. Geneva, Switzerland: World Health Organization; 1999. The World Health Report. p. 110.
4. Hamzaoglu O, Kiliç B. Türkiye Saglik Istatistikleri. Ankara, Turkey: Türk Tabipleri Birligi; 2000.
5. Munk ME, Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl. 1995;20:668-675.
6. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb). 2003;83(1-3):98-106.
7. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994;84(12):4008-4027.
8. Raja A. Immunology of tuberculosis. Indian J Med Res. 2004;120(4):213-232.
9. Sharma S, Bose M. Role of cytokines in immune response to pulmonary tuberculosis. Asian Pac J Allergy Immunol. 2001;19(3):213-219.
10. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 1990;142(3):725-735.
11. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with mycobacterium tuberculosis. Infect Immun. 1995;63(8):3231-3234.
12. Lai CK, Ho S, Chan CH, et al. Cytokine gene expression profile of circulating CD4 + T cells in active pulmonary tuberculosis. Chest. 1997;111(3):606-611.
13. Bonecini-Almeida MG, Ho JL, Boechat N, et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun. 2004;72(5):2628-2634.
14. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect Immun. 1993;61(3):3482-3489.
15. Bekker LG, Maartens G, Steyn L, Kaplan G. Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis. 1998;178(2):580-584.
16. Pereira CB, Palaci M, Leite OH, Duarte AJ, Benard G. Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations. Microbes Infect. 2004;6(1):25-33.
17. O'Neill LA, Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol. 1998;63(6):650-657.
18. Portales-Perez DP, Baranda L, Layseca E, et al. Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients. Clin Diagn Lab Immunol. 2002;9(2):299-307.
19. Surcel HM, Troye-Blomberg M, Paulie S, et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 1994;81(2):171-176.
20. Torres M, Herrera T, Villareal H, Rich EA, Sada E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of mycobacterium tuberculosis. Infect Immun. 1998;66(1):176-180.
21. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci USA. 1997;94(8):3926-3931.
22. Lee JS, Song CH, Kim CH, et al. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30 kDa antigen in recurrent pulmonary tuberculosis patients. Med Microbiol Immunol (Berl). 2003;192(2):61-69.
23. Dlugovitzky D, Bay ML, Rateni L, et al. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin Exp Immunol. 2000;122(3):343-349.
24. Munk ME, Mayer P, Anding P, Feldmann K, Kaufmann SH. Increased numbers of interleukin-12-producing cells in human tuberculosis. Infect Immun. 1996;64(3):1078-1080.
25. Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol. 1999;115(1):110-113.
26. Dlugovitzky D, Torres-Morales A, Rateni L, et al. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol. 1997;18(3):203-207.
27. Kart L, Buyukoglan H, Tekin IO, et al. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. Mediators Inflamm. 2003;12(1):9-14.
28. Ameglio F, Casarini M, Capoluongo E, Mattia P, Puglisi G, Giosue S. Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int J Tuberc Lung Dis. 2005;9(1):98-104.
29. Nakaya M, Yoneda T, Yoshikawa M, et al. The evaluation of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) level in peripheral blood of patients with active pulmonary tuberculosis. Kekkaku. 1995;70(8):461-466.
30. Kawaguchi H, Ina Y, Ito S, et al. Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis. Kekkaku. 1996;71(3):259-265.
31. Tang S, Xiao H, Fan Y, et al. Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 2002;25(6):325-329.
32. Olobo JO, Geletu M, Demissie A, et al. Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol. 2001;53(1):85-91.
33. Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol. 1988;27(2):187-194.
34. Vilcek J, Klion A, Henriksen-DeStefano D, et al. Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol. 1986;6(2):146-151.
35. Morosini M, Meloni F, Marone Bianco A, et al. The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7(10):994-1000.
36. Berktas M, Guducuoglu H, Bozkurt H, Onbasi KT, Kurtoglu MG, Andic S. Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis. J Int Med Res. 2004;32(3):324-330.
37. Bermudez LE, Young LS. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of mycobacterium avium complex. J Immunol. 1988;140(9):3006-3013.
38. Rook GA, Steele J, Fraher L, et al. Vitamin D3, gamma interferon, and control of proliferation of mycobacterium tuberculosis by human monocytes. Immunology. 1986;57(1):159-163.
39. Denis M. Killing of mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol. 1991;84(2):200-206.
40. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol. 1995;154(1):465-473.
41. Condos R, Rom WN, Liu YM, Schluger NW. Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med. 1998;157(3 pt 1):729-735.
42. Toossi Z, Ellner JJ. The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol. 1998;87(2):107-114.
43. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factorbeta and interleukin-10. J Biol Chem. 1992;267(32):23301-23308.
44. Fiorenza G, Rateni L, Farroni MA, Bogue C, Dlugovitzky DG. TNF-alpha, TGF-beta and no relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett. 2005;98(1):45-48.
45. van Crevel R, Karyadi E, Preyers F, et al. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis. 2000;181(3):1194-1197.
46. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun. 1996;64(4):1351-1356.
47. Zhong D, Dong L, Liang Q. Alteration of interferongamma and interleukin-12 released by bronchoalveolar lavage cells from pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 2000;23(9):552-555.
48. Sanchez FO, Rodriguez JI, Agudelo G, Garcia LF. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun. 1994;62(12):5673-5678.
49. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991;254(5029):277- 279.
50. Barnes PF, Chatterjee D, Abrams JS, et al. Cytokine production induced by mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol. 1992;149(2):541-547.
51. Taha RA, Kotsimbos TC, Song YL, Menzies D, Hamid Q. IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med. 1997;155(3):1135-1139.
52. Ribeiro-Rodrigues R, Resende Co T, Johnson JL, et al. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol. 2002;9(4):818-823.